Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jasper Therapeutics Inc. (NQ: JSPR ) 21.23 +0.15 (+0.71%) Streaming Delayed Price Updated: 1:50 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 115,945 Open 20.97 Bid (Size) 21.04 (2) Ask (Size) 21.24 (1) Prev. Close 21.08 Today's Range 20.31 - 21.83 52wk Range 4.000 - 31.01 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024 May 14, 2024 JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Performance YTD +211.93% +211.93% 1 Month -12.71% -12.71% 3 Month -10.87% -10.87% 6 Month +99.53% +99.53% 1 Year +44.42% +44.42% More News Read More Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday May 06, 2024 Via Benzinga JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023 March 06, 2024 Via InvestorPlace Jasper Therapeutics: Q3 Earnings Insights November 09, 2023 Via Benzinga Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying February 12, 2024 Via Benzinga Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 18, 2024 Via Benzinga Where Jasper Therapeutics Stands With Analysts May 15, 2023 Via Benzinga Jasper Therapeutics: Q1 Earnings Insights May 12, 2023 Via Benzinga 7 Analysts Have This to Say About Jasper Therapeutics February 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 17, 2024 Via Benzinga Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 18, 2023 From Jasper Therapeutics, Inc. Via GlobeNewswire Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update November 09, 2023 From Jasper Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session September 11, 2023 Via Benzinga Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update August 11, 2023 From Jasper Therapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 August 11, 2023 Via Benzinga Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus July 13, 2023 Via MarketBeat Topics Retirement Exposures Pension Jasper Therapeutics, Inc. (NASDAQ: JSPR) Featured in Coverage of the Inaugural EF Hutton Global Conference May 02, 2023 Via Investor Brand Network $4M Bet On Jasper Therapeutics? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying April 12, 2023 Via Benzinga Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket April 12, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 12, 2023 Via InvestorPlace Jasper Therapeutics Touts Encouraging Data From Briquilimab Conditioning In Inherited Bone Marrow Disorder February 17, 2023 Via Benzinga Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket February 17, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday February 17, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
